The long-term objective of the proposed research is to show how activation of the receptor tyrosine kinase/Ras/MAP kinase signaling pathway regulates cell fates. This conserved signaling pathway is used in multiple tissues throughout development, but the cell physiological response to this pathway can be dramatically different. In mammals, this signaling pathway regulates growth and differentiation of fibroblasts, neurons and myoblasts. In flies and works, this signaling pathway plays a central and crucial role in establishing the body plan and controlling neuronal and epithelial pattern formation. Much is known about the chain of events leading to the activation of the last signal transduction protein (MAP kinase). However, little is known about the events that occur that MAP kinase activation. How does MAP kinase activation lead to changes in cell shape and gene expression, and what are the effector molecules that link MAP kinase activation to the expression of new cell fates? Many tissues respond to the RTK/Ras/MAP kinase signaling pathway, and this core signaling pathway has been intensively studied. However, the differences in each tissue that define the specificity of the response to the signaling pathway are poorly understood. How can a common Ras/MAP kinase signaling pathway generate such diverse signaling outcomes? A simple hypothesis is that different tissues express different MAP kinase substrates, such that activation of these different effectors by MAP kinase phosphorylation leads to different cellular responses. The proposed research will elucidate the mechanisms linking MAP kinase activation to changes in gene expression and will define how MAP kinase signaling specificity is regulated using a simple model system that is readily amenable to powerful genetic and molecular genetic approaches: induction of the vulva in the nematode C. elegans. The first goal is to functionally analyze a tissue specific transcription factor that may mediate the response and determine the specificity to MAP kinase signaling. The second goal is to genetically identify and molecularly analyze new genes that function downstream of MAP kinase in vulval cell fate determination. The third goal is to molecularly define the response to MAP kinase signaling using microarrays to globally identify changes in gene expression caused by MAP kinase signaling.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM043977-10
Application #
6138423
Study Section
Molecular Cytology Study Section (CTY)
Program Officer
Zatz, Marion M
Project Start
1991-01-01
Project End
2002-12-31
Budget Start
2000-01-01
Budget End
2000-12-31
Support Year
10
Fiscal Year
2000
Total Cost
$322,674
Indirect Cost
Name
Stanford University
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305